Top Markets
Coin of the day
NutraLife BioSciences, Inc. NutraLife BioSciences, Inc.

NutraLife BioSciences, Inc.

NLBS
Pozycja w akcjach #41573
NutraLife BioSciences, Inc., operating with its subsidiaries, specializes in... NutraLife BioSciences, Inc., operating with its subsidiaries, specializes in the creation, production, and distribution of a diverse range of health-oriented products. This includes nutraceuticals, dietary supplements, general wellness items, and a significant line of cannabidiol (CBD) products. The company's CBD portfolio is comprehensive, featuring cannabinoid-rich hemp oil sourced from industrial hemp, tinctures, and a variety of topical solutions like lotions and oils designed for direct skin application to alleviate pain or inflammation. Their CBD offerings also extend to face creams, massage oils, nutraceutical sprays enhanced with CBD, and specialized products for pets. In addition to its CBD range, NutraLife BioSciences also manufactures skincare items and hand sanitizers. Customers can acquire the company's products directly from its website, nutralifebiosciences.com, or through a network of private label distributors, other online retailers, and traditional brick-and-mortar stores. Established in 2010 and based in Coconut Creek, Florida, the enterprise was previously known as NutraFuels, Inc. It officially adopted its current name, NutraLife BioSciences, Inc., in March 2019.
Cena akcji
$0.0001
Ostatnia synchronizacja: 2024-12-11
Kapitalizacja rynkowa
$16.04K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel NutraLife BioSciences, Inc. (NLBS)

Kategoria

Zyski dla NutraLife BioSciences, Inc. (NLBS)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych NutraLife BioSciences, Inc., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy NutraLife BioSciences, Inc. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów